Parexel to be acquired by eqt private equity and goldman sachs asset management

Boston and durham, n.c., july 02, 2021 (globe newswire) -- parexel, a leading global clinical research organization (cro) focused on development and delivery of innovative new therapies to advance patient health, today announced the execution of a definitive merger agreement under which it will be acquired by eqt ix fund (“eqt private equity”) and the private equity business within goldman sachs asset management (“goldman sachs”) from pamplona capital management lp for $8.5 billion.
GS Ratings Summary
GS Quant Ranking